Titre:
  • Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Auteur:Hudeček, Jan; Voorwerk, Leonie; van Seijen, Maartje; Nederlof, Iris; de Maaker, Michiel; van den Berg, Jose; van de Vijver, Koen K; Sikorska, Karolina; Adams, Sylvia; Demaria, Sandra; Viale, Giuseppe; Nielsen, Torsten O; Badve, Sunil; Michiels, Stefan; Symmans, William Fraser; Sotiriou, Christos; Rimm, David L; Hewitt, Stephen M; Denkert, Carsten; Loibl, Sibylle; Loi, Sherene; Bartlett, John M S; Pruneri, Giancarlo; Dillon, Deborah A; Cheang, Maggie C U; Tutt, Andrew M; Hall, Jacqueline Anne; Kos, Zuzana; Salgado, Roberto; Kok, Marleen; Horlings, Hugo Mark; International Immuno-Oncology Biomarker Working Group,
Informations sur la publication:NPJ breast cancer, 6, page (15)
Statut de publication:Publié, 2020-01-01
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Médecine pathologie humaine
Mots-clés:Biomarkers
Breast cancer
Tumour biomarkers
Tumour immunology
Langue:Anglais
Identificateurs:urn:issn:2374-4677
info:doi/10.1038/s41523-020-0155-1
info:pii/155
info:pmid/32436923
PMC7217941